文献速递冠心病血脂与心血管预防

基因组联合血脂与炎症生物标志物预测冠心病风险:英国生物银行研究

Combining Genomics With Lipid and Inflammatory Biomarkers to Predict Coronary Artery Disease Risk: UK Biobank Study.
PubMed 文献 · J Am Coll Cardiol · 2026-03-18

基于英国生物银行215,695名40-69岁参与者的12年随访,评估冠状动脉疾病多基因风险评分(CAD PRS)、LDL-C、Lp(a)和hsCRP对冠心病(CAD)的预测价值。四种标志物均与CAD独立相关,且年龄越轻关联越强;四标志物联合模型C统计量为0.753,高于汇集队列方程的0.740,连续净重分类指数为32.0%。

要点

  • CAD PRS、LDL-C、Lp(a)、hsCRP均独立预测冠心病,年龄越轻关联越强。
  • 四项标志物均升高者冠心病风险为无升高者的4.65倍。
  • 联合模型C统计量0.753,优于汇集队列方程的0.740,连续NRI为32.0%。

核心结论

  • CAD PRS、LDL-C、hsCRP和Lp(a)与冠心病存在独立的年龄和性别特异性关联,联合检测四项标志物可能改善中年男性和女性的冠心病风险预测。

研究设计与样本

  • 英国生物银行前瞻性队列研究,纳入215,695名40至69岁且基线具有CAD PRS、LDL-C、Lp(a)和hsCRP值的参与者,随访12年评估冠心病发病。

主要发现

  • 12年随访期间,4,721名男性和2,425名女性发生冠心病。
  • 各标志物升高的冠心病风险比(HR)分别为:CAD PRS 1.79(95%CI:1.70-1.89)、LDL-C 1.60(95%CI:1.48-1.66)、Lp(a) 1.20(95%CI:1.12-1.29)、hsCRP 1.64(95%CI:1.57-1.72)。
  • CAD PRS在男性中的关联(每标准差HR:1.49;95%CI:1.45-1.54)强于女性(每标准差HR:1.37;95%CI:1.31-1.44;交互P≤0.001)。
  • 所有标志物在较年轻年龄组中赋予更高的HR(P<0.0001)。
  • 四项标志物均升高者相比无升高者冠心病风险增加4.65倍。

关键数值与推荐

  • 四标志物联合模型C统计量为0.753,高于汇集队列方程的0.740。
  • 联合模型在年轻个体中C统计量亦更高,与汇集队列方程相比连续净重分类指数为32.0%。

临床怎么用

  • 在中年人群中联合检测CAD PRS、LDL-C、Lp(a)和hsCRP可能有助于识别冠心病高风险个体,补充传统风险评分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Coronary artery disease (CAD) polygenic risk score (PRS), low-density-lipoprotein cholesterol (LDL-C), lipoprotein(a) (Lp(a)), and high-sensitivity C-reactive protein (hsCRP) are biomarkers that predict CAD. It is unclear whether integrating genomics with lipid and inflammatory biomarkers could complement traditional risk scores in identifying people at risk of CAD. OBJECTIVES: This study assesses the predictive value of CAD PRS, LDL-C, Lp(a), and hsCRP for incident CAD across different age and sex groups. METHODS: Participants (n = 215,695) from the UK Biobank aged 40 to 69 years with baseline CAD PRS, LDL-C, Lp(a), and hsCRP values were followed for 12 years to assess the incidence of CAD. We evaluated a multivariable-adjusted Cox model that included all 4 biomarkers, net reclassification index, C-statistics, and population attributable risk across different age and sex groups. RESULTS: Over a 12-year follow-up, 4,721 men and 2,425 women developed CAD. The HRs for incident CAD associated with each biomarker elevation were 1.79 (95% CI: 1.70-1.89) for CAD PRS, 1.60 (95% CI: 1.48-1.66) for LDL-C, 1.20 (95% CI: 1.12-1.29) for Lp(a), and 1.64 (95% CI: 1.57-1.72) for hsCRP. CAD PRS demonstrated a stronger association in men (HR per SD: 1.49; 95% CI: 1.45-1.54) than women (HR per SD: 1.37; 95% CI: 1.31-1.44; P-interaction ≤ 0.001). All biomarkers conferred greater HRs at younger ages (P < 0.0001). Individuals with all biomarkers elevated had a 4.65-fold increased risk of CAD compared with those with no elevated biomarkers. A combined 4-biomarker model had a higher C-statistic of 0.753 compared with the pooled cohort equations (C-statistic of 0.740). The C-statistic of the combined 4-biomarker model was also higher in younger individuals in both sexes and yielded a 32.0% continuous net reclassification index when compared with the pooled cohort equations. CONCLUSIONS: CAD PRS, LDL-C, hsCRP, and Lp(a) show independent age- and sex-specific associations with CAD. Measuring all 4 biomarkers may improve midlife CAD risk prediction for both male and female patients.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Farah R, Kim MS, Truong B, et al. Combining Genomics With Lipid and Inflammatory Biomarkers to Predict Coronary Artery Disease Risk: UK Biobank Study. J Am Coll Cardiol. 2026. PMID: 41848465. doi:10.1016/j.jacc.2026.01.076

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。